首页 › 基金 › Pivotal bioVenture Partners Investment Advisor LLC › BIOA

Pivotal bioVenture Partners Investment Advisor LLC 对 BIOA 的持仓历史

BIOAGE LABS INC · 医疗保健

Pivotal bioVenture Partners Investment Advisor LLC 在 Q3 2026 的 13F 申报中披露持有 BIOA(BIOAGE LABS INC)653,374 股,市值约 US$4.6M,约占其申报组合的 1.89%,在其申报持仓中市值排名第 13 位。 Pivotal bioVenture Partners Investment Advisor LLC 最近 9 个申报季度中有 9 个季度披露了 BIOA 持仓,最早可追溯至 Q3 2024。

最新持仓 (Q3 2026)653.37K 股
申报持仓市值$4.63M
组合权重1.89%
首次申报Q3 2024
最近变动持有
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Pivotal bioVenture Partners Investment Advisor LLC 对 BIOA 的持仓演变

Pivotal bioVenture Partners Investment Advisor LLC 于 Q3 2024 首次披露 BIOA 持仓:527,647 股(约 US$11.0M)。 该持仓在 Q2 2026 达到峰值 653,374 股,市值约 US$16.0M。 在 9 次申报中,Pivotal bioVenture Partners Investment Advisor LLC 1 次增持、0 次减持、7 次保持不变。 最近一期申报(Q3 2026)显示持股 653,374 股、市值约 US$4.6M。

逐季持仓明细

季度股数金额变化
Q3 2024 527.65K $10.98M 新进
Q4 2024 653.37K $3.78M 增持
Q1 2025 653.37K $2.46M 持有
Q2 2025 653.37K $2.70M 持有
Q3 2025 653.37K $3.84M 持有
Q4 2025 653.37K $8.64M 持有
Q1 2026 653.37K $11.43M 持有
Q2 2026 653.37K $16.01M 持有
Q3 2026 653.37K $4.63M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 BIOA 与 13F 数据

BIOA(BIOAGE LABS INC)属于医疗保健行业。我们追踪的基金中还有 61 只申报持有 BIOA,申报仓位最大的包括:a16z Capital Management, L.L.C. (US$79.2M), Cormorant Asset Management, LP (US$58.6M), Sofinnova Investments, Inc. (US$56.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BIOA 的基金

查看 BIOA 的全部基金持有人 →

常见问题

How long has Pivotal bioVenture Partners Investment Advisor LLC held BIOA?

Pivotal bioVenture Partners Investment Advisor LLC has disclosed BIOA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Pivotal bioVenture Partners Investment Advisor LLC's current position in BIOA?

As of Q3 2026, Pivotal bioVenture Partners Investment Advisor LLC holds 653.37K shares of BIOA (BIOAGE LABS INC), valued at $4.63M, representing 1.89% of its reported portfolio and ranking #13.

Has Pivotal bioVenture Partners Investment Advisor LLC been buying or selling BIOA?

In the latest 13F filing (Q3 2026), Pivotal bioVenture Partners Investment Advisor LLC held unchanged its position in BIOA. The position peaked in Q2 2026 at 653.37K shares.

Which other funds hold BIOA?

Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Cormorant Asset Management, LP, Sofinnova Investments, Inc., among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.